Board of Advisors
Tethys is creating a Board of Advisors comprised of individuals who have either successfully commercialized industrial biotechnology and/or directed the marketing of industrial enzymes and/or have biorefinery technical expertise.
Mr. Steve Dubin: Former CEO of Martek Biosciences Corporation (NASDAQ:MATK). Mr. Dubin played a key role in developing Martek’s business from an R&D company to a fully integrated, profitable, commercial organization with over $470M in annual sales. In December of 20120, Martek was acquired by Royal DSM N.V. for $1.1 billion. Mr. Dubin is a Principal at SDA Ventures LLC.